Nalaganje...
Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial
BACKGROUND: Barrett’s esophagus is a premalignant condition that is a risk factor for the development of esophageal adenocarcinoma, a disease whose incidence is rapidly increasing. Because aspirin and other nonsteroidal antiinflammatory drugs, such as celecoxib, may decrease the risk of developing e...
Shranjeno v:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755596/ https://ncbi.nlm.nih.gov/pubmed/17405999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djk112 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|